EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 14.81% over 3 years and 20.14% over 5 years; the trailing 12 months came in at +7.63%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Zimmer Biomet Holdings, Inc. (ZBH)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
Reported quarterly EBITDA; no daily interpolation.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $2.28B | $2.46B | +$174.00M | +7.62% |
| 2024 | $2.23B | $2.28B | +$52.60M | +2.36% |
| 2023 | $1.62B | $2.23B | +$606.70M | +37.39% |
| 2022 | $1.80B | $1.62B | −$175.30M | -9.75% |
| 2021 | $981.50M | $1.80B | +$816.50M | +83.19% |
| 2020 | $2.14B | $981.50M | −$1.16B | -54.21% |
| 2019 | $1.07B | $2.14B | +$1.07B | +99.53% |
| 2018 | $1.86B | $1.07B | −$787.70M | -42.30% |
| 2017 | $1.86B | $1.86B | +$1.60M | +0.09% |
| 2016 | $1.18B | $1.86B | +$680.70M | +57.70% |
| 2015 | $1.41B | $1.18B | −$233.40M | -16.52% |
| 2014 | $1.39B | $1.41B | +$19.00M | +1.36% |
| 2013 | $1.41B | $1.39B | −$16.40M | -1.16% |
| 2012 | $1.38B | $1.41B | +$26.50M | +1.91% |
| 2011 | $1.26B | $1.38B | +$127.10M | +10.11% |
| 2010 | $1.36B | $1.26B | −$99.30M | -7.32% |
| 2009 | $1.37B | $1.36B | −$8.90M | -0.65% |
| 2008 | $1.36B | $1.37B | +$7.50M | +0.55% |
| 2007 | $1.36B | $1.36B | −$5.00M | -0.37% |
| 2006 | $1.24B | $1.36B | +$121.90M | +9.83% |
| 2005 | $944.50M | $1.24B | +$296.20M | +31.36% |
| 2004 | $554.00M | $944.50M | +$390.50M | +70.49% |
| 2003 | $426.20M | $554.00M | +$127.80M | +29.99% |
| 2002 | $271.70M | $426.20M | +$154.50M | +56.86% |
| 2001 | $291.10M | $271.70M | −$19.40M | -6.66% |
| 2000 | $253.00M | $291.10M | +$38.10M | +15.06% |
| 1999 | $237.00M | $253.00M | +$16.00M | +6.75% |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Quarter ended Jun 2026 | $596.90M | +11.5% | +4.4% |
| Quarter ended Mar 2026 | $535.30M | -6.4% | -2.1% |
| Quarter ended Dec 2025 | $571.80M | -9.9% | -12.4% |
| Quarter ended Sep 2025 | $634.90M | +11.0% | +19.7% |
| Quarter ended Jun 2025 | $571.80M | +4.6% | -3.8% |
| Quarter ended Mar 2025 | $546.70M | -16.2% | +8.4% |
| Quarter ended Dec 2024 | $652.60M | +23.0% | +9.6% |
| Quarter ended Sep 2024 | $530.40M | -10.8% | +4.5% |
| Quarter ended Jun 2024 | $594.50M | +17.8% | +4.8% |
| Quarter ended Mar 2024 | $504.50M | -15.3% | -9.8% |
| Quarter ended Dec 2023 | $595.40M | +17.3% | +197.4% |
| Quarter ended Sep 2023 | $507.80M | -10.5% | +6.5% |
| Quarter ended Jun 2023 | $567.10M | +1.4% | +10.4% |
| Quarter ended Mar 2023 | $559.10M | +179.3% | +29.4% |
| Quarter ended Dec 2022 | $200.20M | -58.0% | -42.2% |
| Quarter ended Sep 2022 | $476.70M | -7.2% | +0.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
